Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.55)
# 250
Out of 5,118 analysts
111
Total ratings
57.84%
Success rate
21.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Maintains: Buy | $15 → $6 | $2.43 | +146.91% | 4 | Dec 12, 2025 | |
| PHVS Pharvaris | Maintains: Buy | $32 → $39 | $25.74 | +51.52% | 1 | Dec 4, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $28 → $43 | $24.79 | +73.46% | 8 | Nov 18, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $22 → $19 | $21.82 | -12.92% | 7 | Nov 5, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $10.27 | +192.11% | 1 | Oct 15, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $24.56 | +286.81% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $6.11 | -1.80% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $79.98 | +15.03% | 6 | Sep 23, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $40.55 | -16.15% | 3 | Sep 15, 2025 | |
| SLNO Soleno Therapeutics | Reiterates: Buy | $106 | $47.55 | +122.92% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $10 | $11.08 | -9.75% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $9.14 | +53.17% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $60.04 | +76.55% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $459.78 | +18.75% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $19.72 | +224.54% | 3 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $19.60 | +155.10% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $253.68 | -25.50% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $27.84 | +97.56% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.37 | +434.12% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $13.49 | +26.02% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.25 | +5.26% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $53.97 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $4.30 | +341.86% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.04 | +444.55% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $35.02 | -14.33% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.38 | +2,001.45% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $398.82 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.65 | +395.58% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $17.86 | +11.98% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $33.14 | +271.15% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $26.74 | +101.94% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.20 | +4,900.00% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.16 | - | 3 | Jun 26, 2017 |
Rezolute
Dec 12, 2025
Maintains: Buy
Price Target: $15 → $6
Current: $2.43
Upside: +146.91%
Pharvaris
Dec 4, 2025
Maintains: Buy
Price Target: $32 → $39
Current: $25.74
Upside: +51.52%
Centessa Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $43
Current: $24.79
Upside: +73.46%
Sarepta Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $21.82
Upside: -12.92%
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $10.27
Upside: +192.11%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $24.56
Upside: +286.81%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $6.11
Upside: -1.80%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $79.98
Upside: +15.03%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $40.55
Upside: -16.15%
Soleno Therapeutics
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $47.55
Upside: +122.92%
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $11.08
Upside: -9.75%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $9.14
Upside: +53.17%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $60.04
Upside: +76.55%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $459.78
Upside: +18.75%
Jun 20, 2025
Reiterates: Buy
Price Target: $64
Current: $19.72
Upside: +224.54%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $19.60
Upside: +155.10%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $253.68
Upside: -25.50%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $27.84
Upside: +97.56%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $3.37
Upside: +434.12%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $13.49
Upside: +26.02%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $14.25
Upside: +5.26%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $53.97
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $4.30
Upside: +341.86%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $4.04
Upside: +444.55%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $35.02
Upside: -14.33%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.38
Upside: +2,001.45%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $398.82
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $5.65
Upside: +395.58%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $17.86
Upside: +11.98%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $33.14
Upside: +271.15%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $26.74
Upside: +101.94%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.20
Upside: +4,900.00%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $27.16
Upside: -